BJOG : an international journal of obstetrics and gynaecology
BJOG : an international journal of obstetrics and gynaecology
Audio Summaries
Every issue of BJOG : an international journal of obstetrics and gynaecology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
BJOG : an international journal of obstetrics and gynaecology covers research in these specialties.
Recent summaries
The latest articles summarized from BJOG : an international journal of obstetrics and gynaecology.
Efficacy and Safety of the Oral Gonadotropin-Releasing Hormone Antagonist DW4902 for Heavy Menstrual Bleeding in Uterine Fibroids: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial.
Nov 18, 2026
This Phase II randomized, double-blind, placebo-controlled trial asked whether the oral GnRH antagonist DW4902 (160, 240, or 320 mg daily) could effectively control heavy menstrual bleeding in premenopausal women with uterine fibroids. In 71 women, 73–100% of DW4902 recipients achieved the primary endpoint of PBAC <10 during Weeks 6–12 (p<0.0001), with amenorrhea, fibroid volume reduction, and pain relief also improved. Adverse events were mostly mild, with modest, reversible lumbar spine bone density changes, supporting short-term safety and efficacy, though longer-term data are needed.
Routine Prenatal Ultrasound at 36 Weeks: Impact on Obstetric Clinical Outcomes.
Nov 18, 2026
This single-centre retrospective study asked whether adding a routine 36-week ultrasound scan, tied to a predefined management pathway, changes obstetric outcomes in nearly 37,000 term singleton pregnancies. Using interrupted time-series analysis comparing periods before and after the 2020 switch from targeted scanning, the authors found that the proportion of SGA infants delivered at 37-38 weeks rose, breech detection improved from about 78% to nearly 90%, and NICU admissions and third- and fourth-degree perineal tears decreased. These associations suggest a universal late-third-trimester scan may influence management in useful ways, though the retrospective, non-randomised design limits causal conclusions.
Microplastics and Nanoplastics in Follicular Fluid and in Vitro Fertilisation Outcomes: A Prospective Cohort Study.
Nov 18, 2026
This prospective cohort study of 203 women undergoing IVF in Beijing asked whether microplastic and nanoplastic concentrations in follicular fluid are linked to IVF success. Higher follicular-fluid polyvinyl chloride levels were associated with fewer oocytes retrieved, fewer two-pronuclear zygotes and good-quality embryos, and lower odds of clinical pregnancy and live birth, while polystyrene and polyamide 66 showed no significant associations. Because the findings are observational, they require confirmation in larger, independent cohorts.
Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause.
Nov 18, 2026
This narrative review asks whether local, non-hormonal treatments, particularly injectable hyaluronic acid, can help women with genitourinary syndrome of menopause who cannot or will not use vaginal oestrogen. The authors report that injectable hybrid cooperative complex hyaluronic acid (HCC-HA) shows potential benefit for vaginal dryness and dyspareunia in small studies and one randomised trial (conducted in women with sexual dysfunction rather than strictly defined GSM), with no serious adverse events reported. However, they conclude that evidence is not yet sufficient to make these therapies routine or guideline-recommended, and that larger independent trials with longer follow-up are needed.
Clustering of Maternal and Perinatal Complications Following Fresh and Frozen Embryo Transfer in First-Time Mothers: A Population-Based Cohort Study.
Nov 17, 2026
This population-based cohort study from Denmark, Norway, and Sweden asked how often first-time mothers with singleton pregnancies after frozen embryo transfer, fresh embryo transfer, or natural conception have pregnancies free of maternal and perinatal complications, a single complication, or multiple complications. About three in four pregnancies after frozen or fresh embryo transfer had no complications, compared with four in five after natural conception, and two or more complications occurred in about 1 in 11 ART pregnancies versus 1 in 16 naturally conceived ones. The authors conclude that although complications were more common after ART, the absolute differences were small, which may help set realistic expectations for patients considering or undergoing treatment.
Hormonal Contraception Use and Changes in Body Mass Index: A Cohort Study.
Nov 10, 2026
This Danish cohort study of 47,148 women examined whether hormonal contraceptive use is associated with changes in body mass index between adolescence and adulthood, using height and weight data from the national child health register and adult self-reports from the Safe Choice survey. BMI rose across all groups, but combined oestrogen-progestin users showed the largest increase after more than five years of cumulative use (3.14 points), versus 2.28 points in never-users and 2.47 points in progestin-only users. Oestrogen-containing contraception was associated with a larger BMI increase after 4-5 years of cumulative use compared with never-users, though the observational design means causation cannot be established.
Migration, Duration of Residence and Spontaneous and Iatrogenic Preterm Birth: A Retrospective Cohort Study.
Nov 10, 2026
This retrospective cohort study of 60,806 singleton births in New South Wales, Australia, asked whether the "healthy migrant" effect applies to preterm birth and its iatrogenic and spontaneous subtypes, and whether it varies with length of residence. Both new (<5 years) and established (≥5 years) migrants had lower adjusted odds of preterm birth than Australian-born women, with the reduction driven mainly by iatrogenic preterm birth in both groups, while lower spontaneous preterm birth odds were seen only among new migrants. The association was strongest among women in the most socioeconomically disadvantaged areas, suggesting differences in baseline health, obstetric decision-making, and health-system engagement may contribute.
Mode of Birth and Bleeding Outcomes in Pregnancies at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia: A Retrospective Cohort Study.
Nov 8, 2026
This retrospective cohort study of 73 subsequent pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT) asked whether vaginal delivery increases the risk of intracranial haemorrhage (ICH) in neonates, given that nearly all mothers received weekly antenatal IVIG. Across 44 vaginal deliveries (high- and standard-risk combined), no ICH occurred, and only one neonate developed petechiae, while one antenatal ICH identified before IVIG initiation was noted in the standard-risk group. The authors conclude that vaginal delivery appears safe in HPA-alloimmunised women treated antenatally with IVIG, though the small sample size limits certainty.
Comparative Efficacy and Safety of Modern Treatment Modalities for Genitourinary Syndrome of Menopause: A Systematic Review and Network Meta-Analysis.
Nov 8, 2026
This systematic review and network meta-analysis asked how modern treatments for genitourinary syndrome of menopause (GSM) compare in efficacy and safety. Across 24 randomised trial families (about 4,958 women), local vaginal oestrogen was the only therapy with a statistically significant symptom improvement over placebo/sham/control (SMD 0.34), while prasterone, hyaluronic acid, ospemifene, moisturisers and CO2 laser showed imprecise estimates and evidence certainty was low to very low. The authors conclude that local oestrogen remains the best-supported benchmark, and that CO2 laser and radiofrequency should not be considered equivalent or superior first-line options, favouring individualised stepped care over a definitive treatment hierarchy.
Postpartum Perineal Assessment After Vaginal Birth and Detection of Obstetric Anal Sphincter Injury: A Scoping Review.
Nov 8, 2026
This scoping review (PRISMA-ScR) asked how international guidelines and supporting evidence address postpartum perineal assessment for detecting obstetric anal sphincter injuries (OASIS). The authors reviewed 14 core guidelines, 3 regional documents, and 31 evidence sources, with AGREE II appraisal of formal guidelines. They found that while immediate postpartum assessment is covered, recommendations conflict on digital rectal examination, imaging timing and role, diagnostic escalation, structured follow-up, and implementation aspects such as documentation, training, and audit.
